Literature DB >> 22811352

The characteristics of ABO antibodies in group O Thai blood donors.

Kamontip Khampanon1, Thanaporn Chanprakop, Pramote Sriwanitchrak, Manida Setthakarn, Sineenart Oota, Oytip Nathalang.   

Abstract

This study aimed to characterize anti-A and anti-B hemolysins, IgM, and IgG titers in Thai blood donors. Altogether, 300 serum samples from group O donors at the National Blood Centre, Thai Red Cross Society, were screened for anti-A and anti-B hemolysins and treated with 0.01 M dithiothreitol to characterize IgM and IgG titers by standard tube technique. Antibody titers were compared with hemolysis grade. Male and female ratio = 1:1.3 and ages ranged from 17 to 60 years. The overall prevalence of anti-A and anti-B hemolysins was 69%. Anti-A and anti-B hemolysins comprised 18.3% and 16.7%, respectively and 34% had both antibodies. High titers of anti-A hemolysins were associated with females (P< 0.05), and only anti-B IgM titers were associated with age (P< 0.05). Interestingly, the association of anti-A IgM titers, anti-A IgG titers, and hemolysin grade was demonstrated (P< 0.05). A significant association between hemolysin grade and anti-B IgM titers was found (P< 0.05). The prevalence of anti-A and anti-B hemolysins and high titers of IgM and IgG in Thais are high. Hemolysin grade showed significant associations with IgM titers; therefore, when providing ABO-incompatible platelet transfusion, especially for female plateletpheresis donors, IgM high titers of anti-A and anti-B screening is suggested.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22811352      PMCID: PMC6807638          DOI: 10.1002/jcla.21499

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  19 in total

1.  ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity.

Authors:  R J Benjamin; J H Antin
Journal:  Transfusion       Date:  1999 Nov-Dec       Impact factor: 3.157

2.  Prevalence and titre of alpha and beta haemolysins in blood group 'O' donors in Ilorin.

Authors:  H O Olawumi; P O Olatunji
Journal:  Afr J Med Med Sci       Date:  2001-12

3.  Comparison of IgM and IgG anti-A and anti-B levels in Asian, Caucasian and Negro donors in the North West Thames Region.

Authors:  M Redman; R Malde; M Contreras
Journal:  Vox Sang       Date:  1990       Impact factor: 2.144

Review 4.  ABO and platelet transfusion therapy.

Authors:  L Cooling
Journal:  Immunohematology       Date:  2007

5.  Differences in ABO antibody levels among blood donors: a comparison between past and present Japanese, Laotian, and Thai populations.

Authors:  T Mazda; R Yabe; O NaThalang; T Thammavong; K Tadokoro
Journal:  Immunohematology       Date:  2007

6.  ABO incompatibility due to immunoglobulin G anti-B antibodies presenting with severe fetal anaemia.

Authors:  J H Ziprin; E Payne; L Hamidi; I Roberts; F Regan
Journal:  Transfus Med       Date:  2005-02       Impact factor: 2.019

7.  Characteristics of anti-A and anti-B in black Zimbabweans.

Authors:  J O Adewuyi; C Gwanzura; D Mvere
Journal:  Vox Sang       Date:  1994       Impact factor: 2.144

8.  Acute intravascular hemolysis secondaryto out-of-group platelet transfusion.

Authors:  L G Larsson; V J Welsh; D J Ladd
Journal:  Transfusion       Date:  2000-08       Impact factor: 3.157

9.  Blood-group-A-like substance in a preparation of pneumococcal vaccine.

Authors:  G R Siber; D M Ambrosino; B C Gorgone
Journal:  Ann Intern Med       Date:  1982-05       Impact factor: 25.391

10.  Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy.

Authors:  C D Josephson; N C Mullis; C Van Demark; C D Hillyer
Journal:  Transfusion       Date:  2004-06       Impact factor: 3.157

View more
  5 in total

1.  Evaluation of Magnetized-Erythrocyte Group Antigens to Detect ABO Antibodies.

Authors:  O Nathalang; K Intharanut; P Sriwanitchrak; M Setthakarn; S Duan; H Wang; S Ding; Y Li
Journal:  Indian J Hematol Blood Transfus       Date:  2015-10-29       Impact factor: 0.900

2.  Prevalence of alpha and beta haemolysin among blood group O donors in Bamenda, Cameroon.

Authors:  Victor N Fondoh; Nobert Ndzenjempuh; Tamunjoh Stella; Richard M Fondoh; Charles N Awasom; Rebecca Enow-Tanjong; Egbe P Egbengu; Robert Leke; Njini F N Rose; Denis Nsame
Journal:  Afr J Lab Med       Date:  2022-04-19

3.  Prophylactic strategies for acute hemolysis secondary to plasma-incompatible platelet transfusions: correlation between qualitative hemolysin test and isohemagglutinin titration.

Authors:  Cinthia Silvestre Landim; Francisco Carlos Almeida Gomes; Bernardete Martin Zeza; Alfredo Mendrone-Júnior; Carla Luana Dinardo
Journal:  Rev Bras Hematol Hemoter       Date:  2015-06-03

4.  Lower Levels of ABO Anti-A and Anti-B of IgM, IgG and IgA Isotypes in the Serum but Not the Saliva of COVID-19 Convalescents.

Authors:  Eva M Matzhold; Günther F Körmöczi; Chiara Banfi; Marlies Schönbacher; Camilla Drexler-Helmberg; Ivo Steinmetz; Andrea Berghold; Peter Schlenke; Gabriel E Wagner; Anja Stoisser; Barbara Kleinhappl; Wolfgang R Mayr; Thomas Wagner
Journal:  J Clin Med       Date:  2022-08-02       Impact factor: 4.964

5.  Dangerous universal donors: the reality of the Hemocentro in Belo Horizonte, Minas Gerais.

Authors:  Mariana Martins Godin; Lucas de Oliveira Souza; Luciana Cayres Schmidt; Lauro Mello Vieira; Rejane Silva Diniz; Luci Maria SantAna Dusse
Journal:  Rev Bras Hematol Hemoter       Date:  2016-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.